Soluble Urokinase Plasminogen Activator Receptor as a Marker for Use of Antidepressants

Open Access

Peer-reviewed

Research Article

Eva Haastrup ,

* E-mail: eva.haastrup@rh.regionh.dk

Affiliation Department of Clinical Immunology, the Blood bank, Rigshospitalet, University Hospital of Copenhagen, Copenhagen, Denmark
⨯
Katrine Grau,

Affiliation Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark
⨯
Jesper Eugen-Olsen,

Affiliation Clinical Research Centre, Hvidovre Hospital, University Hospital of Copenhagen, Copenhagen, Denmark
⨯
Christian Thorball,

Affiliation Clinical Research Centre, Hvidovre Hospital, University Hospital of Copenhagen, Copenhagen, Denmark
⨯
Lars Vedel Kessing,

Affiliation Psychiatric Centre, Rigshospitalet, University Hospital of Copenhagen, Copenhagen, Denmark
⨯
Henrik Ullum

Affiliation Department of Clinical Immunology, the Blood bank, Rigshospitalet, University Hospital of Copenhagen, Copenhagen, Denmark
⨯

Reader Comments (0)

Antidepressants
Is the Subject Area "Antidepressants" applicable to this article?

Thanks for your feedback.
Depression
Is the Subject Area "Depression" applicable to this article?

Thanks for your feedback.
Inflammatory diseases
Is the Subject Area "Inflammatory diseases" applicable to this article?

Thanks for your feedback.
Medical risk factors
Is the Subject Area "Medical risk factors" applicable to this article?

Thanks for your feedback.
C-reactive proteins
Is the Subject Area "C-reactive proteins" applicable to this article?

Thanks for your feedback.
Inflammation
Is the Subject Area "Inflammation" applicable to this article?

Thanks for your feedback.
Blood donors
Is the Subject Area "Blood donors" applicable to this article?

Thanks for your feedback.
Women's health
Is the Subject Area "Women's health" applicable to this article?

Thanks for your feedback.